179 related articles for article (PubMed ID: 10049065)
1. Allelic loss of 11q13 as detected by MEN1-FISH is not associated with mutation of the MEN1 gene in lymphoid neoplasms.
Thieblemont C; Pack S; Sakai A; Beaty M; Pak E; Vortmeyer AO; Wellmann A; Zhuang Z; Jaffe ES; Raffeld M
Leukemia; 1999 Jan; 13(1):85-91. PubMed ID: 10049065
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.
Böni R; Vortmeyer AO; Huang S; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1999 Jun; 9(3):249-52. PubMed ID: 10465580
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mutations in patients with multiple endocrine neoplasia type 1.
Bassett JH; Forbes SA; Pannett AA; Lloyd SE; Christie PT; Wooding C; Harding B; Besser GM; Edwards CR; Monson JP; Sampson J; Wass JA; Wheeler MH; Thakker RV
Am J Hum Genet; 1998 Feb; 62(2):232-44. PubMed ID: 9463336
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
[TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of 11q13 sequences in HeLa cells.
Srivatsan ES; Bengtsson U; Manickam P; Benyamini P; Chandrasekharappa SC; Sun C; Stanbridge EJ; Redpath JL
Genes Chromosomes Cancer; 2000 Oct; 29(2):157-65. PubMed ID: 10959095
[TBL] [Abstract][Full Text] [Related]
8. Lack of mutations of exon 2 of the MEN1 gene in endocrine and nonendocrine sporadic tumors.
Costa SC; Nascimento LS; Ferreira FJ; Mattos PS; Camara-Lopes LH; Ward LS
Braz J Med Biol Res; 2001 Jul; 34(7):861-5. PubMed ID: 11449303
[TBL] [Abstract][Full Text] [Related]
9. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
10. PTEN gene alterations in lymphoid neoplasms.
Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
[TBL] [Abstract][Full Text] [Related]
11. Lack of MEN1 gene mutations in 27 sporadic insulinomas.
Cupisti K; Höppner W; Dotzenrath C; Simon D; Berndt I; Röher HD; Goretzki PE
Eur J Clin Invest; 2000 Apr; 30(4):325-9. PubMed ID: 10759881
[TBL] [Abstract][Full Text] [Related]
12. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
13. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
14. Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
Lloyd SE; Pang JT; Pearce SH; Leigh SE; Thakker RV
Hum Genet; 1997 May; 99(5):585-9. PubMed ID: 9150722
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
[TBL] [Abstract][Full Text] [Related]
16. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
17. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
[TBL] [Abstract][Full Text] [Related]
18. MEN1 gene mutation analysis of sporadic adrenocortical lesions.
Görtz B; Roth J; Speel EJ; Krähenmann A; De Krijger RR; Matias-Guiu X; Muletta-Feurer S; Rütmann K; Saremaslani P; Heitz PU; Komminoth P
Int J Cancer; 1999 Jan; 80(3):373-9. PubMed ID: 9935177
[TBL] [Abstract][Full Text] [Related]
19. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
[TBL] [Abstract][Full Text] [Related]
20. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
